At the peak of the second wave in early January, around one in 50 were estimated to have coronavirus. The latest figures confirm the increasing prevalence of coronavirus across England. In the week to ...

What went wrong with the government's planning and buying of vital items like gloves and gowns that cost taxpayers billions ...

All the latest Coronavirus news, updates, health advice and official information from Cornwall and nationally. We will bring ...

In a recent study published in The BMJ, researchers describe hospital admissions associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pediatric patients. Study: ...

A recent Nature Communications study assesses the impact of different coronavirus disease 2019 (COVID-19) vaccine doses on cardiovascular safety in millions of adults in England. Study: Cohort study ...

Findings from the React-2 studies show more than one third of people who had coronavirus reported symptoms lasting at least 12 weeks. This amounts to 5.8% of the whole study population, with 2% ...

Picture is more mixed for language skills, U.K. observational study shows ...

Disparities in long COVID resources exist between disadvantaged and affluent areas, with a widening gap in provision. Approximately 3.3% of the UK population is affected by long COVID, with ...

Simnotrelvir is an oral 3-chymotrypsin–like protease inhibitor that has been found to have in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and potential efficacy ...

In an ongoing international, multifactorial, adaptive platform, randomized, controlled trial, we evaluated simvastatin (80 mg daily) as compared with no statin (control) in critically ill patients ...